Our investigation showed that codon 273 mutant astrocytomas may be more chemosensitive compared to TP53 WT as the OS of codon 273 mutant astrocytoma was significant longer in the chemotherapy-treated group, but not in the ‘no-chemotherapy’ group in two independent cohorts. The gene discussed is TP53; the disease is astrocytoma (excluding glioblastoma).